New Key Statistics Module, Z-Score and F-Score
SHSE:603858 Key Ratios
Market Cap ¥ M | 19,809.22 |
Enterprise Value ¥ M | 22,068.63 |
P/E(ttm) | -- |
PE Ratio without NRI | 38.19 |
Forward PE Ratio | -- |
Price/Book | 1.75 |
Price/Sales | 1.69 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 2.05 |
Revenue (TTM) ¥ M | 11,719.00 |
EPS (TTM) ¥ | -0.17 |
Beneish M-Score | -2.74 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 387.68 |
EV-to-EBITDA | 387.68 |
PEG | -- |
Shares Outstanding M | 1,106.04 |
Net Margin (%) | -1.67 |
Operating Margin % | 6.77 |
Pre-tax Margin (%) | -0.56 |
Quick Ratio | 0.52 |
Current Ratio | 1.28 |
ROA % (ttm) | -0.92 |
ROE % (ttm) | -1.67 |
ROIC % (ttm) | 29.27 |
Dividend Yield % | 0.70 |
Altman Z-Score | 2.34 |
SHSE:603858 Number of Guru Trades
SHSE:603858 Volume of Guru Trades
Gurus Latest Trades with SHSE:603858
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603858 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shandong Buchang Pharmaceuticals Co Ltd Insider Transactions
No Available Data